Search
for
Sort by
Research 61–90 of 1000+
- Gene Expression of Osteopontin in Alopecia Areata? A Case-Controlled Study
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- 570 Examining cutaneous disease activity as an outcome measure for clinical trials in dermatomyositis
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables
- High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study
- Quality of Life with Alopecia Areata versus Androgenetic Alopecia Assessed Using Hair Specific Skindex-29
- The study of premature canities and its association in tertiary care hospital
- withdrawn
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Etiopathogenesis of Alopecia Areata
- Role of Hair Prostheses (Wigs) in Patients with Severe Alopecia Areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
- Mild-to-moderate COVID-19 is not associated with worsening of alopecia areata: A retrospective analysis of 32 patients
- Determinants of marginal traction alopecia in African girls and women
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- European expert consensus statement on the systemic treatment of alopecia areata
- Dermoscopic Analysis of Patients with and without Poor Prognostic Indicators in Alopecia Areata – A Comparative Study
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- BH31 Dermoscopic analysis of patients with and without poor prognostic indicators in alopecia areata: a comparative study
- Alopecia areata: A review
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Response of alopecia areata of the beard to oral tofacitinib
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy